DANIELLE GANGE: Open Payments
NPI 1851831549 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 34 payments from 9 companies in 2025. Trend: 2023 $677 · 2024 $619 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $181 |
| E.R. Squibb & Sons, L.L.C. | 4 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Indivior Inc. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $19 |
Products named: VRAYLAR, COBENFY, REXULTI, CAPLYTA, TRINTELLIX, SUBLOCADE, INVEGA SUSTENNA, INGREZZA.
Industry payments across VA — which companies pay providers there.
